Vimarsana
Biggest News Aggregation in the World

Infection Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Infection Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Infection Diagnostics Today - Breaking & Trending Today

Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech - Vimarsana News

Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech

ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics , biomedical systems/specialty IVD, and microbiology ELITech offers the...

Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup - Vimarsana News

Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup

28.02.2024 - Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, to acquire ELITechGroup, for €870 ... Seite 1

Global Respiratory Infection Diagnostic Market Research - Vimarsana News

Global Respiratory Infection Diagnostic Market Research

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The

Respiratory Infection Diagnostic Technology Market Analysis Report 2024: Multiplex Advancements and Geographic Expansion 2023-2027 - Vimarsana News

Respiratory Infection Diagnostic Technology Market Analysis Report 2024: Multiplex Advancements and Geographic Expansion 2023-2027

/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Executive and Consultant Guides 2024-2028"...

MALDI Biotyper: the future of food quality and safety - Vimarsana News

MALDI Biotyper: the future of food quality and safety

Here, Dr Gerald Larrouy-Maumus and Matteo Viganò reveal how new methodologies are advancing testing capabilities.